Differences in donor CXCR4 expression levels are correlated with functional capacity and therapeutic outcome of angiogenic treatment with endothelial colony forming cells

Biochemical and Biophysical Research Communications

Volumn 398, Issue 4, 2010, Pages 627-633

  Oh, Bae Jun ^a   Kim, Deog Kyeom ^b   Kim, Byoung Jae ^b   Yoon, Kang Sup ^b   Park, Sang Gyu ^c   Park, Kyong Soo ^d   Lee, Myung Shik ^a   Kim, Kwang Won ^a   Kim, Jae Hyeon ^a,c  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Seoul National University Boramae Hospital   (South Korea)

^c Seoul National University Hospital   (South Korea)

^d Seoul National University College of Medicine   (South Korea)

Author keywords

CXCR4; Endothelial colony forming cells; Migration; Neovascularization; SDF 1

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE; PLERIXAFOR; PROTEIN KINASE B; STROMAL CELL DERIVED FACTOR 1ALPHA;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CAPILLARY DENSITY; CELL ISOLATION; CELL MIGRATION; COLONY FORMING CELL; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; FUNCTIONAL STATUS; HINDLIMB; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LEG ISCHEMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; TISSUE BLOOD FLOW; UMBILICAL CORD BLOOD;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CXCL12; ENDOTHELIUM, VASCULAR; HETEROCYCLIC COMPOUNDS; HUMANS; LIVING DONORS; MALE; MICE; MICE, NUDE; MYOCARDIAL ISCHEMIA; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, CXCR4; STEM CELL TRANSPLANTATION; STEM CELLS; UMBILICAL CORD;

EID: 77955420231     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.06.108     Document Type: Article

References (25)

1. Takahashi T., Kalka C., Masuda H., et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 1999, 5:434-438.
2. Kawamoto A., Gwon H.C., Iwaguro H., et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 2001, 103:634-637.
3. Raffi S., Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat. Med. 2003, 9:702-712.
4. Hur J., Yoon C.H., Kim H.S., et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler. Thromb. Vasc. Biol. 2004, 24:288-293.
5. Ingram D.A., Caplice N.M., Yoder M.C. Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. Blood 2005, 106:1525-1531.
6. Yoder M.C., Mead L.E., Prater D., et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007, 109:1801-1809.
7. Beeres S.L., Atsma D.E., van Ramshorst J., et al. Cell therapy for ischemic heart disease. Heart 2008, 94:1214-1226.
8. De Falco E., Porcelli D., Torella A.R., et al. SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 2004, 104:3472-3482.
9. Peled A., Kollet O., Ponomaryov T., et al. The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice. Blood 2000, 95:3289-3296.
10. Yamaguchi J., Kusano K.F., Masuo O., et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 2003, 107:1322-1328.
11. Mohle R., Bautz F., Rafii S., et al. The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. Blood 1998, 91:4523-4530.
12. Jaffe E.A., Nachman R.L., Becker C.G., et al. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 1973, 52:2745-2756.
13. -ΔΔCT method. Methods 2001, 25:402-408.
14. Kawasaki K., Smith R.S., Hsieh C.M., et al. Activation of the phosphatidylinositol 3-kinase/protein kinase Akt pathway mediates nitric oxide-induced endothelial cell migration and angiogenesis. Mol. Cell. Biol. 2003, 23:5726-5737.
15. Couffinhal T., Silver M., Zheng L.P., et al. Mouse model of angiogenesis. Am. J. Path. 1998, 152:1667-1679.
16. Kucia M., Jankowski K., Reca R., et al. CXCR4-SDF-1 signaling, locomotion, chemotaxis and adhesion. J. Mol. Histol. 2004, 35:233-245.
17. Smadja D.M., Bieche I., Uzan G., et al. PAR-1 activation on human late endothelial progenitor cells enhances angiogenesis in vitro with upregulation of the SDF-1/CXCR4 system. Arterioscler. Thromb. Vasc. Biol. 2005, 25:2321-2327.
18. Nagano M., Yamashita T., Hamada H., et al. Identification of functional endothelial progenitor cells suitable for the treatment of ischemic tissue using human umbilical cord blood. Blood 2007, 110:151-160.
19. Zheng H., Fu G., Dai T., et al. Migration of endothelial progenitor cells mediated by stromal cell-derived factor-1alpha/CXCR4 via PI3K/Akt/eNOS signal transduction pathway. J. Cardiovasc. Pharmacol. 2007, 50:274-280.
20. Kuhlmann C.R., Schaefer C.A., Reinhold L., et al. Signalling mechanisms of SDF-induced endothelial cell proliferation and migration. Biochem. Biophys. Res. Commun. 2005, 335:1107-1114.
21. Kanda S., Mochizuki Y., Kanetake H. Stromal cell-derived factor-1alpha induces tube-like structure formation of endothelial cells through phosphoinositide 3-kinase. J. Biol. Chem. 2003, 278:257-262.
22. Ceradini D.J., Kulkarni A.R., Callaghan M.J., et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat. Med. 2004, 10:858-864.
23. Dupont A., Fontana P., Bachelot-Loza C., et al. An intronic polymorphism in the PAR-1 gene is associated with platelet receptor density and the response to SFLLRN. Blood 2003, 101:1833-1840.
24. Cohen O.J., Paolucci S., Bende S.M., et al. CXCR4 and CCR5 genetic polymorphisms in long-term nonprogressive human immunodeficiency virus infection: lack of association with mutations other than CCR5-Δ32. J. Virol. 1998, 72:6215-6217.
25. Xiao Q., Ye S., Oberhollenzer F., et al. SDF1 gene variation is associated with circulating SDF1a level and endothelial progenitor cell number - the bruneck study. PLoS One 2008, 3:e4061.